174 related articles for article (PubMed ID: 16980658)
1. Expression of granulysin in polymyositis and inclusion-body myositis.
Ikezoe K; Ohshima S; Osoegawa M; Tanaka M; Ogawa K; Nagata K; Kira JI
J Neurol Neurosurg Psychiatry; 2006 Oct; 77(10):1187-90. PubMed ID: 16980658
[TBL] [Abstract][Full Text] [Related]
2. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
3. Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies.
Choi YC; Dalakas MC
Neurology; 2000 Jan; 54(1):65-71. PubMed ID: 10636127
[TBL] [Abstract][Full Text] [Related]
4. Shared blood and muscle CD8+ T-cell expansions in inclusion body myositis.
Dimitri D; Benveniste O; Dubourg O; Maisonobe T; Eymard B; Amoura Z; Jean L; Tiev K; Piette JC; Klatzmann D; Herson S; Boyer O
Brain; 2006 Apr; 129(Pt 4):986-95. PubMed ID: 16455793
[TBL] [Abstract][Full Text] [Related]
5. The immunopathologic and inflammatory differences between dermatomyositis, polymyositis and sporadic inclusion body myositis.
Dalakas MC; Sivakumar K
Curr Opin Neurol; 1996 Jun; 9(3):235-9. PubMed ID: 8839618
[TBL] [Abstract][Full Text] [Related]
6. Plasma cells in muscle in inclusion body myositis and polymyositis.
Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
[TBL] [Abstract][Full Text] [Related]
7. Polymyositis mediated by T lymphocytes that express the gamma/delta receptor.
Hohlfeld R; Engel AG; Ii K; Harper MC
N Engl J Med; 1991 Mar; 324(13):877-81. PubMed ID: 1705662
[TBL] [Abstract][Full Text] [Related]
8. Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositis persists over time. Studies in repeated muscle biopsies.
Amemiya K; Granger RP; Dalakas MC
Brain; 2000 Oct; 123 ( Pt 10)():2030-9. PubMed ID: 11004120
[TBL] [Abstract][Full Text] [Related]
9. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
Kleefeld F; Uruha A; Schänzer A; Nishimura A; Roos A; Schneider U; Goebel HH; Schuelke M; Hahn K; Preusse C; Stenzel W
Neurology; 2022 Nov; 99(20):e2212-e2222. PubMed ID: 36195449
[TBL] [Abstract][Full Text] [Related]
10. Association of inclusion body myositis with T cell large granular lymphocytic leukaemia.
Greenberg SA; Pinkus JL; Amato AA; Kristensen T; Dorfman DM
Brain; 2016 May; 139(Pt 5):1348-60. PubMed ID: 26920676
[TBL] [Abstract][Full Text] [Related]
11. Impaired expression of perforin and granulysin in CD8+ T cells at the site of infection in human chronic pulmonary tuberculosis.
Andersson J; Samarina A; Fink J; Rahman S; Grundström S
Infect Immun; 2007 Nov; 75(11):5210-22. PubMed ID: 17664265
[TBL] [Abstract][Full Text] [Related]
12. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies.
Hiniker A; Daniels BH; Lee HS; Margeta M
Acta Neuropathol Commun; 2013 Jul; 1():29. PubMed ID: 24252466
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
[TBL] [Abstract][Full Text] [Related]
14. Granulysin-producing cytotoxic T cells in the mucocutaneous lesions of Behçet disease: a distinct inflammatory response from erythema nodosum.
Yamasaki O; Morizane S; Aochi S; Ogawa K; Oono T; Iwatsuki K
Clin Exp Dermatol; 2011 Dec; 36(8):903-7. PubMed ID: 21883401
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the significance of expanded CD8
McLeish E; Sooda A; Slater N; Kachigunda B; Beer K; Paramalingam S; Lamont PJ; Chopra A; Mastaglia FL; Needham M; Coudert JD
Front Immunol; 2023; 14():1153789. PubMed ID: 37063893
[TBL] [Abstract][Full Text] [Related]
16. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis.
Morosetti R; Gliubizzi C; Sancricca C; Broccolini A; Gidaro T; Lucchini M; Mirabella M
Am J Pathol; 2012 Apr; 180(4):1603-13. PubMed ID: 22314077
[TBL] [Abstract][Full Text] [Related]
17. CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15.
Ma LL; Spurrell JC; Wang JF; Neely GG; Epelman S; Krensky AM; Mody CH
J Immunol; 2002 Nov; 169(10):5787-95. PubMed ID: 12421959
[TBL] [Abstract][Full Text] [Related]
18. The role of CD4 and CD8 cytotoxic T lymphocytes in the formation of viral vesicles.
Morizane S; Suzuki D; Tsuji K; Oono T; Iwatsuki K
Br J Dermatol; 2005 Nov; 153(5):981-6. PubMed ID: 16225610
[TBL] [Abstract][Full Text] [Related]
19. Muscle Transcriptomics Shows Overexpression of Cadherin 1 in Inclusion Body Myositis.
Ikenaga C; Date H; Kanagawa M; Mitsui J; Ishiura H; Yoshimura J; Pinal-Fernandez I; Mammen AL; Lloyd TE; Tsuji S; Shimizu J; Toda T; Goto J
Ann Neurol; 2022 Mar; 91(3):317-328. PubMed ID: 35064929
[TBL] [Abstract][Full Text] [Related]
20. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
